Compare MQ & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MQ | STAA |
|---|---|---|
| Founded | 2010 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2021 | 1995 |
| Metric | MQ | STAA |
|---|---|---|
| Price | $15.84 | $27.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $5.36 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 3.6M | 634.0K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | ★ $624,884,000.00 | $239,442,000.00 |
| Revenue This Year | $16.89 | $30.82 |
| Revenue Next Year | $16.36 | $8.41 |
| P/E Ratio | ★ N/A | $279.70 |
| Revenue Growth | ★ 23.25 | N/A |
| 52 Week Low | $3.70 | $15.59 |
| 52 Week High | $17.65 | $35.87 |
| Indicator | MQ | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 82.99 | 44.97 |
| Support Level | $4.13 | $23.75 |
| Resistance Level | $17.65 | $31.17 |
| Average True Range (ATR) | 0.52 | 1.35 |
| MACD | 1.06 | -0.17 |
| Stochastic Oscillator | 87.27 | 33.70 |
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.